AnaptysBio Inc (ANAB) USD0.001

Sell:$23.92Buy:$23.95$0.83 (3.32%)

NASDAQ:0.22%
Market closed | Prices delayed by at least 15 minutes
Sell:$23.92
Buy:$23.95
Change:$0.83 (3.32%)
Market closed | Prices delayed by at least 15 minutes
Sell:$23.92
Buy:$23.95
Change:$0.83 (3.32%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
26 March 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
347,441$21.60$7,504,725.60401,646
25 March 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
3,000$21.42$64,267.50749,087
22 March 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
145,940$22.78$3,325,184.52752,087
16 February 2024
Eric J LoumeauCOO
Sell
Option/Award related
5,000$25.00$125,000.003,240
30 January 2024
Dennis MulroyCFO
Sell
Regular sell transaction (market)
3,065$23.63$72,425.34964
8 January 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
6,866$21.81$149,747.46898,027
8 January 2024
Paul F LizzulChief Level Officer
Sell
Tax related
2,554$21.81$55,702.7410,118
8 January 2024
Dennis MulroyCFO
Sell
Tax related
2,180$21.81$47,545.804,029
8 January 2024
Eric J LoumeauCOO
Sell
Tax related
2,305$21.81$50,272.053,240
22 November 2023
Eric J LoumeauCOO
Sell
Regular sell transaction (market)
882$14.19$12,515.580

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
26 March 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
347,441$21.60$7,504,725.60401,646
22 March 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
145,940$22.78$3,325,184.52752,087
8 January 2024
Daniel R. (Dan) FagaCEO
Sell
Tax related
6,866$21.81$149,747.46898,027
16 February 2024
Eric J LoumeauCOO
Sell
Option/Award related
5,000$25.00$125,000.003,240
18 September 2023
Dennis MulroyCFO
Sell
Option/Award related
3,895$19.32$75,236.60964

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.